Life Extension Magazine®

Nutritional Strategies to Preserve Memory and Cognition

As we age, it becomes crucial to take steps to preserve healthy neuronal structure and function. Find out what the best-documented nutrients are to achieve optimal neuronal function while quelling the inflammation that ignites Alzheimer’s and vascular dementia.

Scientifically reviewed by: Dr. Gary Gonzalez, MD, in January 2021. Written by: Laurie Barclay, MD.

In numerous studies, neuroscientists warn that the United States and other Western nations face a tidal wave of mind-destroying dementia that threatens to decimate the “golden years” of the soon-to-be-retired baby-boom generation.

In the US alone, dementia is already epidemic among the elderly: nearly one third of adults over the age of 80 are literally losing their minds.1,2 This shockingly high number is expected to skyrocket further in the coming decades.

More evidence that Alzheimer’s is spreading like wildfire comes from the landmark Cognitive Function and Aging study, which found that fully one third of elderly subjects who died with no clinical signs of dementia had autopsy evidence of Alzheimer’s disease. In other words, these adults were likely spared the afflictions of Alzheimer’s only because they died of other causes before memory loss became apparent!3

The good news is, declining brain function during aging is not inevitable. In fact, “senile” dementias may merely reflect wholly preventable biochemical processes that are commonly seen with advancing age. Middle-aged adults who have yet to experience the onset of forgetfulness or mild cognitive impairment should act now to avoid it. Those who are already experiencing these symptoms should implement strategies to prevent the onset of full-blown dementia.3

Ensuring attention to enhanced brain nutrition may help preserve brain tissue and function with age. In this article, we present a two-pronged strategy that involves fueling brain cells with the nutrients needed for optimal nerve function, while quelling the inflammatory fires that ignite Alzheimer’s disease and vascular dementia.4,5 Many of these nutrients are currently in use throughout Europe as prescription medications, but are available as dietary supplements in the US. Targeted nutritional strategies may well be our best bet for maintaining ideal brain health with aging and averting the coming epidemic of dementia.

Brain Nutrition Basics

There is still no cure for senile dementias once they develop, and our risk of acquiring these dreaded diseases climbs steeply with increasing age. Therefore, it is essential to take preventive action against cognitive decline as soon as possible.3,6 Fortunately, recent breakthroughs in understanding brain function—and how it is compromised both during aging and in specific dementias—can help us choose therapeutic agents that support robust brain health, even with advancing age.

Nutritional supplements that optimize cognitive health and function include those required for the synthesis and preservation of acetylcholine—a neurotransmitter central to memory function—as well as those with anti-inflammatory and anticoagulant properties:

Alzheimer’s dementia disrupts nerve pathways that utilize acetylcholine, resulting in memory loss, cognitive impairment, and sleep disturbances.7,8

Furthermore, in Alzheimer’s disease, accumulation of the toxic beta-amyloid protein inflames vital brain structures.9

Finally, by preventing blood clots and “thinning” the blood, anticoagulants can help prevent strokes that result in disabling vascular dementia, while improving sluggish circulation in brain areas deprived of the oxygen and glucose they require for daily functioning.

We will now examine several nutritional supplements that play critically important roles in supporting brain health. Uridine boosts brain energy while protecting nerve cells and promoting their regeneration. GPC (glycerophosphocholine) and phosphatidylserine increase acetylcholine synthesis. Vinpocetine is a powerful anti-inflammatory and anticoagulant agent. Ashwagandha prevents the degradation of brain cells and acetylcholine. Blueberries and grape seed extract fight inflammation and toxic beta-amyloid buildup in the brain.

Uridine: Boosting Brain Cell Communication

One of the most promising biological compounds for enhancing healthy brain structure and cognitive function is uridine. Found in living organisms ranging from humans to bacteria, uridine is a nucleoside, or a combination of a sugar (ribose) with uracil. Nucleosides such as uridine are building blocks for RNA, the biochemical cousin of DNA that serves as a template in gene expression. Uridine is so important to brain development that it is included in human infant formulas. Animal experiments have demonstrated that rats incorporate uridine in their brain RNA during learning exercises.10 However, uridine is essential for effective brain function throughout the human life span.11,12

When orally ingested, uridine crosses the blood-brain barrier to reach brain cells. Once this happens, it increases levels of CDP-choline, which is required for the synthesis of phosphatidylcholine and ultimately of the essential neurotransmitter acetylcholine. Evidence suggests that increased brain levels of phosphatidylcholine improve cognitive function.13,14 Growing evidence also indicates that uridine is a major building block for the synthesis of nerve cell membranes, suggesting that it could play a role in managing various neurodegenerative diseases.15

Neuroscientists consider gerbils to be an excellent animal model for studying diseases of the human brain. When gerbils were given a combination of uridine, choline, and the omega-3 fatty acid DHA (docosahexaenoic acid)—all important components of cell membranes—their brain levels of phosphatidylcholine rose an impressive 45%.16 Because Alzheimer’s patients demonstrate damaged synapses and depleted levels of uridine, DHA, and choline, this finding is particularly striking. Phosphatidylcholine is crucial for nerve cell growth and repair, and specifically for optimal function of the synapses, the junctions where nerve cells communicate with nerve and other types of cells.17 This supplement combination also increased proteins critical to nerve function by 38-102%, suggesting that it actually increased the number of nerve cell membranes containing synapses.16

Since the brains of Alzheimer’s patients contain fewer, smaller synapses, reduced levels of synaptic proteins, and decreased cell membrane components—including choline and DHA—it stands to reason that supplementing with these agents may be useful in treating the disease.16 Scientists are now conducting human clinical trials to assess the effects of this nutrient combination in treating Alzheimer’s.

Uridine also enhances the growth of neurites, which are projections from nerve cells that facilitate the cells’ connections with other brain cells. Uridine also helps stabilize nerve cell membranes18 and enhances their release of the crucial neuro-transmitter dopamine, boosting the brain’s ability to transmit messages.17

Animal experiments suggest that uridine promotes optimal cognitive function even in instances of memory impairment. In rats with hypertension-induced memory loss, supplemental uridine and choline improved their selective attention and spatial learning abilities.19 Similarly, uridine protected against malnutrition-induced impairment of memory and learning by preventing adverse changes in the hippocampus,20 the brain area considered essential for long-term memory and associated with the degenerative changes seen in Alzheimer’s disease.

Another animal study suggests that in addition to its effects on brain structure and function, uridine may help promote improved mood. Rats given uridine and omega-3 fatty acids displayed improved performance on a behavioral test demonstrated to predict antidepressant effects in humans. Remarkably, the combined antidepressant effect was similar to that of prescription antidepressant agents.21

Abundant evidence thus suggests that uridine supports healthy nerve cell membranes and neurite outgrowth, as well as the release of brain neurotransmitters. These effects have been linked with improvements in memory, learning ability, and mood, and hold promise in preventing and managing neurodegenerative diseases such as Alzheimer’s.

GPC: Stabilizing and Reversing Cognitive Impairment

GPC (glycerophosphocholine), a compound related to phosphatidylcholine, has the remarkable ability to forestall, stabilize, and even partially reverse cognitive impairment in the early stages of senile dementia.6,22 Available in Europe only as the prescription drug Gliatilin®, GPC can be obtained over the counter as a dietary supplement in the US. GPC has been found to be well tolerated, with few side effects.6

Medically, Alzheimer’s is usually treated with drugs such as donepezil (Aricept®) and rivastigmine (Exelon®) that block the enzyme acetylcholinesterase from breaking down acetylcholine at the synapse, or connection between two nerves. Known as acetylcholinesterase inhibitors, these medications allow acetylcholine to act at the synapse for longer periods, thereby counteracting the reduced activity in nerve pathways that use acetylcholine.

Unlike drugs that inhibit the breakdown of acetylcholine, GPC actually stimulates the manufacture of new acetylcholine.

Promising animal studies suggest that GPC may help prevent memory loss in humans. Compared to controls, aging rats fed GPC lose fewer nerve connections in the hippocampus, the brain region crucial for memory and learning.23-25 The GPC-fed rats were also protected against a decline in nerve pathways utilizing acetylcholine26 and impairment of higher learning and memory capacities.27

GPC may protect and enhance communication between nerves via its effect on nerve growth factor, a naturally occurring substance that regulates acetylcholine receptors. With aging, nerve growth factor receptors typically decrease. GPC promotes the growth, repair, and increased expression of nerve growth factor receptors in the cerebellar cortex, a brain region responsible for coordination and movement control.28

GPC demonstrates its versatility by boosting brain function via several mechanisms. It stimulates release of the neurotransmitter GABA (gamma-aminobutyric acid), making more GABA available to brain cells. Dwindling levels of GABA in the elderly may partly account for early cognitive impairment, contributing to the dementia, mood disorders, and psychoses seen in degenerative brain conditions such as Alzheimer’s and Huntington’s disease.29

Clinical trials have confirmed the benefits of GPC seen in the laboratory studies. In a multicenter study of patients with probable Alzheimer’s disease, GPC improved cognition and was well tolerated.30 In another large, multicenter Italian study of more than 2,000 patients with recent stroke or “mini-stroke” (transient ischemic attack) who received GPC for six months, 71% had normal cognitive function or only mild forgetfulness when the study ended. The authors concluded that the trial confirms GPC’s efficacy in supporting the cognitive recovery of patients with acute stroke or mini-stroke.31

In a well-controlled, multicenter study in Mexico, GPC significantly improved cognitive function in 261 patients with mild-to-moderate Alzheimer’s disease.32 The patients were randomly assigned to receive either 1200 mg of GPC or placebo daily for six months, and both groups were similarly impaired before entering the study.

On several standardized psychological tests of cognitive function, patients who received GPC scored better than those who received placebo. A measure of cognitive function substantially improved in the GPC group, but worsened in the placebo group. Compared to placebo, the GPC group also fared better in behavioral improvement and standardized physician ratings. The study findings support GPC’s efficacy in treating the cognitive symptoms of dementia disorders such as Alzheimer’s.32

What makes these results particularly encouraging is that they resemble those obtained through the use of Alzheimer’s drugs such as Aricept® and Exelon®. Unlike those drugs, however, GPC is easy to tolerate, with fewer side effects.32

In a review of 13 published clinical trials involving 4,054 patients with age-related memory loss or vascular dementia caused by stroke or mini-stroke (transient ischemic attack), scientists concluded that GPC produced consistent improvements in memory and attention, and significantly improved patients’ clinical condition, even when tested in a variety of experimental settings.6

The scientists also noted that GPC effectively relieved the cognitive symptoms of chronic cerebral deterioration. Furthermore, patients using GPC demonstrated clinical results that were equivalent or superior to control groups under active pharmaceutical treatment. The researchers hope to conduct further studies to examine GPC’s role in supporting the recovery of patients who have suffered a stroke.

Phosphatidylserine: A Versatile Memory Enhancer

Phosphatidylserine plays an extraordinarily varied role in supporting brain health. It enhances the availability of acetylcholine,33 lowers levels of the stress hormone cortisol, and promotes the release of dopamine, an important neurotransmitter known to improve mood and movement control.

Phosphatidylserine also supports the function of many vital enzymes, acts as an antioxidant to combat free-radical damage, and quells inflammation that can exert deleterious effects in the brain.34 In Europe and Japan, phosphatidylserine is sold as a prescription drug to treat memory and learning dysfunction, but it is available as a nutritional supplement in the United States.

Humans manufacture phosphatidylserine to maintain the structure and function of cell membranes, but its production in the body declines with advancing age. Aged rats with cognitive deficits have demonstrated decreased phosphatidylserine in the hippocampus,35 and subjects with a genetically determined type of cognitive deficit exhibit low phosphatidylserine levels in nerve cell membranes.36

When aged rats were given phosphatidylserine for two months, their performance on an age-related memory impairment test improved significantly, indicating better memory function. Phosphatidylserine supplementation restored the rats’ acetylcholine release and energy metabolism in nerve endings to levels typically seen in young rats.37

Further animal studies suggest that phosphatidylserine acts as an antidepressant agent.38 This finding could have far-ranging implications for elderly humans, in whom depression is often confused clinically with cognitive impairment.

By stimulating acetylcholine production,39 phosphatidylserine has proven useful in clinical trials of patients with cognitive impairment.5 These include an open study in patients with age-related cognitive decline,40 well-controlled, randomized trials in patients with senile dementia,41 and a study in Alzheimer’s patients who exhibited the stiffness and rigidity associated with Parkinson’s disease.42

A review of the available research indicates that while phosphatidylserine may help improve memory in elderly patients,43 its effects may be most pronounced in early cognitive impairment44—an observation that underscores the vital importance of beginning supplementation with brain-nourishing nutrients like phosphatidylserine early in life.

A leading scientist at the Alzheimer’s Prevention Foundation has suggested that phosphatidylserine may be a useful component in a lifestyle and nutrition program aimed at preventing Alzheimer’s disease.45 He concludes that memory loss is not an inevitable consequence of aging, and that Alzheimer’s can be prevented or reversed using an integrated approach that includes phosphatidylserine and other brain-supportive nutrients.

Although phosphatidylserine is generally safe and well tolerated,46,47 it may increase the blood-thinning effect of heparin, and therefore should not be used with medications that thin the blood without consulting a physician.48

Nutritional Strategies to Preserve Memory and Cognition: What You Need to Know

As adults age, they become increasingly vulnerable to impaired memory and cognitive function, which can foreshadow the development of Alzheimer’s disease and other forms of dementia.

Scientists have made great advances in unraveling the physiological changes that precipitate and accompany the declining health of the brain and central nervous system. These findings have led to the development of nutritional strategies to preserve and enhance the structure and function of the nervous system with aging.

Uridine contributes to the structure of essential brain cell components while supporting communication between nerve cells, changes that have been associated with improved memory and mood.

GPC (glycerophosphocholine) supports synthesis of the essential neurotransmitter acetylcholine, while boosting memory function.

Phosphatidylserine boosts acetylcholine levels and contributes to healthy brain cell membranes, with benefits for cognition and mood. Phosphatidylserine may be even more effective when combined with the omega-3 fatty acid DHA.

Vinpocetine enhances metabolism and blood flow in the brain, and may provide support for conditions such as vascular dementia and ischemic stroke.

Like drugs used to treat Alzheimer’s, the herb ashwagandha helps prevent the breakdown of the brain neurotransmitter acetylcholine. Ashwagandha further enhances the growth of neurites, which facilitate communication among neurons.

Blueberries fight the memory impairment associated with free radicals and beta-amyloid plaques in the brain. Similarly, grape seed extract protects brain cells from the toxic effects of oxidative stress and beta amyloid.

The hormone pregnenolone supports nerve cell growth in the brain’s memory center and enhances acetylcholine release.

A proactive approach to preserving and enhancing cognitive function using natural therapies may provide the best protection against mind-robbing dementia and Alzheimer’s disease.

Phosphatidylserine and DHA: Synergistic Support for Brain Cells

Phosphatidylserine may be even more beneficial for brain and nervous system health when coupled with the omega-3 fatty acid DHA.

DHA is a major structural and functional component of the central nervous system, accounting for 30-50% of the total fatty acid content of the human brain. In infants and children, DHA is essential for the brain’s growth and functional development. It also helps support normal brain function in adults, including learning and memory. Low levels of DHA, by contrast, are associated with an increased risk for Alzheimer’s.49

In the brain, DHA combines enzymatically with phosphatidylserine to form nerve cell membrane components that support healthy nerve function. Substantial laboratory research suggests that phosphatidylserine’s ability to improve cognitive skills is greatly increased in the presence of DHA.50

Furthermore, the combination of DHA and phosphatidylserine powerfully supports energy production in brain cells. Scientists from the National Institutes of Health believe that phosphatidylserine with attached DHA is among the most critically important molecules for healthy brain function, and that phosphatidylserine works optimally in the presence of abundant levels of DHA.51

Researchers have developed an innovative phosphatidylserine-DHA (PS-DHA) compound designed to optimally support brain cell structure and function. To evaluate its effects on memory, they examined middle-aged rats with accelerated brain aging. While DHA alone showed minimal effects, PS-DHA substantially protected against the memory-robbing effects of brain aging.52

This unique combination of PS-DHA was also examined in a randomized, double-blind, placebo-controlled study of people with attention deficit hyperactivity disorder (ADHD). At the end of three months, those receiving the PS-DHA compound had a total response to treatment of 47%, compared to just 19% in the placebo group. These findings suggest that the phosphatidylserine-DHA combination may improve behavioral and learning disabilities in ADHD patients.52

Vinpocetine: Enhancing Cerebral Blood Flow

The brain health benefits of vinpocetine, derived from the periwinkle flower, are widely recognized in Europe, where it is available only by prescription to treat symptoms of age-related memory impairment.

By improving sluggish cerebral blood flow, vinpocetine enhances the brain’s use of oxygen and glucose.53 Vinpocetine also increases electrical conductivity between nerve cells and supports the activity of nerve pathways related to mental alertness.54 When combined with the popular herb ginkgo biloba, vinpocetine speeds the processing of short-term working memory in normal adults.55

Ginkgo Biloba

By enhancing vasodilation (relaxation of blood vessels), vinpocetine offers targeted benefits for cognitive dysfunction related to vascular disease involving vessels that supply the brain with blood.5 In three studies of older adults with memory impairment related to poor brain circulation or dementia, vinpocetine produced significantly more improvement than placebo in tests of attention, concentration, and memory.43

In a well-controlled trial of 203 patients with mild-to-moderate dementia, 30 or 60 mg of vinpocetine taken daily for four months was deemed safe and was associated with substantial improvements relative to placebo in ratings of overall status, cognitive performance, and severity of illness.56

By interfering with blood clotting at several points during the chain reaction that ultimately causes ischemic stroke, vinpocetine may even protect high-risk individuals from this devastating disease.57 Vinpocetine appears to work by blocking the activation of voltage-sensitive channels for calcium and sodium,58 and by preventing release of potentially toxic glutamate and free radicals.59,60

Because vinpocetine may inhibit blood clotting, it should not be used with Coumadin® or other blood thinners, except under a doctor’s recommendation.

Pregnenolone Supports Nerve Health

One of the most powerful strategies for supporting nervous system health with aging is to ensure optimal levels of the hormone pregnenolone. Synthesized from cholesterol in the mitochondria of all cells, pregnenolone serves as a precursor for numerous essential hormones in the body, including dehydroepiandrosterone (DHEA), estrogens, progesterone, and testosterone.83

As individuals grow older, they experience a dramatic decline in pregnenolone production, as well as in the hormones for which pregnenolone is a precursor.84-86 Declining levels of these essential hormones have been linked with many disorders that commonly accompany aging.

Scientists have noted that levels of pregnenolone are intimately connected with cognitive performance. In fact, pregnenolone directly influences release of the crucial neurotransmitter acetylcholine in several key brain areas involved in memory, learning, cognition, and sleep-wake cycles. Furthermore, administration of pregnenolone reverses the decline in new nerve growth (neurogenesis) that commonly occurs in disorders like Alzheimer’s disease. In particular, pregnenolone dramatically enhances nerve cell growth in the hippocampus, the brain region responsible for memory, which undergoes marked deterioration in Alzheimer’s patients.87,88

Supplemental pregnenolone helps promote a youthful mind and body by contributing to optimal hormone levels, supporting acetylcholine activity, and promoting nerve cell growth in the brain’s memory center.

Since pregnenolone may affect hormone levels, those with hormonally related cancers such as prostate or breast cancer should avoid using pregnenolone.

Ashwagandha: Brain Support Through Stress Relief

The herb ashwagandha (Withania somnifera) has long been used to boost energy and blood supply, reduce inflammation, and increase longevity. Modern science is now uncovering ashwagandha’s benefits for cognitive health.60,61

Ashwagandha has been shown to alleviate stress, which not only influences hormonal status and various bodily systems, but also directly affects brain function. In one study, rats were subjected to stress and evaluated for changes in brain cells, particularly in the hippocampus. Control animals kept under stress-free conditions exhibited no changes; however, in the stressed animals, 85% of brain cells examined showed signs of degeneration. When ashwagandha was administered to stressed subjects, the number of degraded brain cells was reduced by 80%.62

Ashwagandha has shown promise in treating Parkinson’s and Alzheimer’s diseases. For example, a recent study in laboratory animals showed that administering ashwagandha extract significantly and dose-dependently reversed all studied parameters of Parkinson’s-type neurodegeneration.63 In treating Alzheimer’s, physicians often rely on acetylcholinesterase-inhibitor drugs like Aricept®, which block the degradation of the neurotransmitter acetylcholine in order to slow the symptoms and progression of the disease. Ashwagandha extract likewise acts as an acetylcholinesterase inhibitor, and may thus help to preserve cognitive function and memory by protecting acetylcholine from breakdown.64

In any situation of cognitive decline, regeneration of the neuronal network may present a promising therapeutic option. Japanese researchers found that ashwagandha helped promote the regeneration and outgrowth of neurites that facilitate communication between nerve cells. Additionally, ashwagandha produced improvements in memory in a mouse model of Alzheimer’s disease.65

Blueberries: Antioxidant Protection for Brain Health

Neuroscientists are continually searching for natural agents that can protect brain cells from the devastating effects of oxidative stress and inflammation. Blueberries are rich in the powerful antioxidant phytochemicals known as polyphenols, which include proanthocyanidins that are particularly beneficial for brain health.66-69

A recent report found that blueberry extracts exert the same anti-inflammatory and antioxidant activities as the whole fruit.70 Anthocyanidin molecules from such extracts have been shown to cross the blood-brain barrier, making them accessible to neurons.71

When free radicals attack delicate brain cells, they disrupt optimal cellular function and often cause age-related cognitive decline.72 In an experimental rat model, a diet supplemented with plant-derived antioxidants reversed age-related decline in memory and cognition.73 Other studies have shown that increasing dietary intake of antioxidant-rich fruits and vegetables can maintain optimal neuronal function and cognition well into old age.74-76

In one study, scientists discovered that supplementation with blueberries prevented memory loss in aged rats. Researchers fed one group of rats a diet supplemented with blueberries and fed another group a control diet. The animals were then tested for object-recognition memory. The blueberry-fed rats performed significantly better than the control group, suggesting that supplementation with blueberries restored youthful levels of function in the aging brain.75

Intriguingly, the researchers also tested for levels of nuclear factor-kappa beta (NFkB) in the rats after supplementation with blueberries. A naturally occurring compound in cells, NFkB increases production of inflammatory mediators that often initiate degenerative diseases. The scientists found that NFkB levels were significantly lower in rats fed blueberries compared to controls, and that when NFkB levels were lower, the rats scored higher on memory tests.75

Animal studies also indicate that blueberries help maintain high levels of new cell generation in the hippocampus, the brain area that suffers extensive damage in Alzheimer’s disease.77

Oxidative stress is a major factor in the development of Alzheimer’s, along with overproduction of the beta-amyloid protein, which appears to cause cell destruction. The result is damaged cells that are then unable to manufacture or respond normally to the neurotransmitter acetylcholine.

A group of scientists sought to determine whether blueberries have a protective effect on rats bred to have Alzheimer’s disease.78 Astonishingly, they determined that a blueberry-supplemented diet caused Alzheimer’s-bred rats to perform normally on tests of memory and motor behavior. A surprising finding was that levels of destructive beta-amyloid protein in the test animals’ brains did not differ from those of normal rats. The researchers concluded that a diet incorporating blueberries may help overcome genetic predispositions to Alzheimer’s disease.

Other studies of blueberries and cognitive health have found that blueberries provide important protection against destructive inflammation in the brain.79 Brain memory regions of young and old rats fed either a blueberry diet or control diet were subjected to an inflammatory challenge and then examined for production of a protein that would indicate a normal protective response to stress. The protein level in the blueberry-fed aged rats was completely restored within four hours of the inflammatory stimulus. This kind of rapid effect suggests that blueberry supplementation could improve neuroprotective responses to diseases with a mixed oxidative and inflammatory cause, such as Alzheimer’s.

Grape Seed Extract: Guarding Against Senile Plaque Formation

The brain’s extraordinarily complex circuitry generates massive amounts of oxygen free radicals that may play an important role in the impairment of healthy brain activity that commonly accompanies aging.

Rich in polyphenols, grape seed extract is considered one of nature’s most potent antioxidants. Researchers believe that grape seed’s antioxidant properties confer broad-spectrum protection against premature aging, disease, and decay; in fact, grape seed extract packs 20 times more antioxidant power than vitamin E and 50 times more antioxidant power than vitamin C.80 These attributes have led many scientists to suggest that grape seed extract is an essential nutrient for maintaining optimal brain health and function.

Grape seed extract not only improves blood circulation by strengthening capillaries, arteries, and veins, but also prevents the formation of senile plaques that can severely damage the brains of those with dementia.81 For example, South Korean scientists treated the brain cells of rats with grape seed extract before exposing them to the toxic beta-amyloid protein. Beta amyloid promotes the development of plaques that accumulate in the brains of patients with Alzheimer’s disease. Treatment with grape seed extract conferred significant protection on the rat brain cells. While the untreated rat brain cells sustained acute free-radical damage and subsequently died, cells treated with grape seed extract suffered little damage.81

In research published in 2006, Indian scientists sought to evaluate grape seed extract’s effects on the accumulation of oxidative DNA damage seen in normal aging. They administered grape seed extract to young and aged albino rats for 30 days. In rats that received the extract, grape seed extract inhibited the accumulation of age-related oxidative DNA damage in the spinal cord and in various brain regions such as the cerebral cortex, striatum, and hippocampus—the very sites involved in thinking, processing, and memory that are most degraded in neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease.82

Conclusion: Prevention Is the Best Brain Medicine

An abundance of scientific evidence indicates that any program to protect the brain from dementia and other ravages of aging should incorporate compounds that have been shown to stimulate brain energy metabolism, boost acetylcholine levels, and protect against inflammation, thrombosis, and oxidative stress. By taking advantage of recent advances in our understanding of nerve cell function, cognition and memory, and how these processes are disrupted during normal aging, health-conscious adults can devise an individualized anti-aging program utilizing the most potent brain-protective nutrients available today.

Supplements such as uridine, GPC, phosphatidylserine, DHA, vinpocetine, ashwagandha, blueberries, and grape seed extract work via numerous mechanisms to provide natural, broad-spectrum support for optimal brain health and function. Because it is so much easier to protect the health of your brain cells than it is to restore their function once damage has manifested, it makes sense to begin a preventive program as soon as possible. When it comes to protecting and preserving brain health, “an ounce of prevention is worth a pound of cure” is truly a no-brainer.


1. Hofman A, Rocca WA, Brayne C, et al. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol. 1991 Sep;20(3):736-48.

2. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987 Nov;76(5):465-79.

3. Burns A, Zaudig M. Mild cognitive impairment in older people. Lancet. 2002 Dec 14;360(9349):1963-5.

4. Klegeris A, McGeer PL. Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging. 2002 Sep;23(5):787-94.

5. Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev. 1999 Jun;4(3):144-61.

6. Parnetti L, Amenta F, Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Mech Ageing Dev. 2001 Nov;122(16):2041-55.

7. Ritchie K, Kildea D. Is senile dementia “age-related” or “ageing-related”?—evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995 Oct 7;346(8980):931-4.

8. Ritchie K, Lovestone S. The dementias. Lancet. 2002 Nov 30;360(9347):1759-66.

9. Paris D, Town T, Parker T, Humphrey J, Mullan M. A beta vasoactivity: an inflammatory reaction. Ann NY Acad Sci. 2000 Apr;903:97-109.

10. Smith JE, Heistad GT, Thompson T. Uptake of 3H-uridine into brain and incorporation into brain RNA of rats exposed to various training tasks - a biochemical analysis. Pharmacol Biochem Behav. 1975 May;3(3):447-54.

11. Itoh T, Quastel JH. Ribonucleic acid biosynthesis in adult and infant rat brain in vitro. Science. 1969 Apr 4;164(875):79-80.

12. MacKinnon PC, Simpson RA, Maclennan C. In vivo and in vitro techniques used in the study of RNA synthesis in the brains of rats and mice at various ages from birth to senility. J Anat. 1969 Mar;104(Pt 2):351-60.

13. Blusztajn JK, Liscovitch M, Richardson UI. Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. Proc Natl Acad Sci USA. 1987 Aug;84(15):5474-7.

14. Cansev M, Watkins CJ, van der Beek EM, Wurtman RJ. Oral uridine-5’-monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Res. 2005 Oct 5;1058(1-2):101-8.

15. Cansev M. Uridine and cytidine in the brain: their transport and utilization. Brain Res Brain Res Rev. 2006 Sep;52(2):389-97.

16. Wurtman RJ, Ulus IH, Cansev M, et al. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 2006 May 9;1088(1):83-92.

17. Wang L, Pooler AM, Albrecht MA, Wurtman RJ. Dietary uridine-5’-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. J Mol Neurosci. 2005;27(1):137-45.

18. Pooler AM, Guez DH, Benedictus R, Wurtman RJ. Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12 [corrected]. Neuroscience. 2005;134(1):207-14.

19. De Bruin NM, Kiliaan AJ, De Wilde MC, Broersen LM. Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. Neurobiol Learn Mem. 2003 Jul;80(1):63-79.

20. Teather LA, Wurtman RJ. Chronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished rats. J Nutr. 2006 Nov;136(11):2834-7.

21. Carlezon WA, Jr., Mague SD, Parow AM, et al. Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry. 2005 Feb 15;57(4):343-50.

22. Manev H, Uz T, Sugaya K, Qu T. Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J. 2000 Jul;14(10):1464-9.

23. Ricci A, Bronzetti E, Vega JA, Amenta F. Oral choline alfoscerate counteracts age-dependent loss of mossy fibres in the rat hippocampus. Mech Ageing Dev. 1992;66(1):81-91.

24. Amenta F, Ferrante F, Vega JA, Zaccheo D. Long term choline alfoscerate treatment counters age-dependent microanatomical changes in rat brain. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Sep;18(5):915-24.

25. Amenta F, Bronzetti E, Ricci A, et al. Nucleus basalis magnocellularis lesions decrease histochemically reactive zinc stores in the rat brain: effect of choline alphoscerate treatment. Eur J Histochem. 1995;39(4):281-8.

26. Amenta F, Franch F, Ricci A, Vega JA. Cholinergic neurotransmission in the hippocampus of aged rats: influence of L-alpha-glycerylphosphorylcholine treatment. Ann NY Acad Sci. 1993 Sep 24;695:311-3.

27. Drago F, Mauceri F, Nardo L, et al. Behavioral effects of L-alpha-glycerylphosphorylcholine: influence on cognitive mechanisms in the rat. Pharmacol Biochem Behav. 1992 Feb;41(2):445-8.

28. Vega JA, Cavallotti C, del Valle ME, Mancini M, Amenta F. Nerve growth factor receptor immunoreactivity in the cerebellar cortex of aged rats: effect of choline alfoscerate treatment. Mech Ageing Dev. 1993 Jun;69(1-2):119-27.

29. Cummings JL, et al. Neurobiological basis of behavior. In: Coffey CE, Cummings JL, eds. Textbook of Geriatric Neuropsychiatry. American Psychiatric Press; 1994: 72-96.

30. Parnetti L, Abate G, Bartorelli L, et al. Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer’s type. Drugs Aging. 1993 Mar;3(2):159-64.

31. Barbagallo SG, Barbagallo M, Giordano M, Meli M, Panzarasa R. alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial. Ann NY Acad Sci. 1994 Jun 30;717:253-69.

32. De Jesus Moreno MM. Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther. 2003 Jan;25(1):178-93.

33. Amenta F, Parnetti L, Gallai V, Wallin A. Treatment of cognitive dysfunction associated with Alzheimer’s disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? Mech Ageing Dev. 2001 Nov;122(16):2025-40.

34. Kingsley M. Effects of phosphatidylserine supplementation on exercising humans. Sports Med. 2006;36(8):657-69.

35. Ulmann L, Mimouni V, Roux S, Porsolt R, Poisson JP. Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. Prostaglandins Leukot Essent Fatty Acids. 2001 Mar;64(3):189-95.

36. Lomnitski L, Oron L, Sklan D, Michaelson DM. Distinct alterations in phospholipid metabolism in brains of apolipoprotein E-deficient mice. J Neurosci Res. 1999 Nov 15;58(4):586-92.

37. Suzuki S, Yamatoya H, Sakai M, et al. Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats. J Nutr. 2001 Nov;131(11):2951-6.

38. Castilho JC, Perry JC, Andreatini R, Vital MA. Phosphatidylserine: an antidepressive or a cognitive enhancer? Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jul;28(4):731-8.

39. Pepeu G, Spignoli G. Nootropic drugs and brain cholinergic mechanisms. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13 SupplS77-S88.

40. Schreiber S, Kampf-Sherf O, Gorfine M, et al. An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. Isr J Psychiatry Relat Sci. 2000;37(4):302-7.

41. Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, Ylieff M. Double-blind randomized controlled study of phosphatidylserine in senile demented patients. Acta Neurol Scand. 1986 Feb;73(2):136-40.

42. Funfgeld EW, Baggen M, Nedwidek P, Richstein B, Mistlberger G. Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer’s type (SDAT). Prog Clin Biol Res. 1989;317:1235-46.

43. McDaniel MA, Maier SF, Einstein GO. “Brain-specific” nutrients: a memory cure? Nutrition. 2003 Nov;19(11-12):957-75.

44. Jorissen BL, Brouns F, Van Boxtel MP, et al. The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr Neurosci. 2001;4(2):121-34.

45. Khalsa DS. Integrated medicine and the prevention and reversal of memory loss. Altern Ther Health Med. 1998 Nov;4(6):38-43.

46. Jorissen BL, Brouns F, Van Boxtel MP, Riedel WJ. Safety of soy-derived phosphatidylserine in elderly people. Nutr Neurosci. 2002 Oct;5(5):337-43.

47. Blokland A, Honig W, Brouns F, Jolles J. Cognition-enhancing properties of subchronic phosphatidylserine (PS) treatment in middle-aged rats: comparison of bovine cortex PS with egg PS and soybean PS. Nutrition. 1999 Oct;15(10):778-83.

48. van den Besselaar AM. Phosphatidylethanolamine and phosphatidylserine synergistically promote heparin’s anticoagulant effect. Blood Coagul Fibrinolysis. 1995 May;6(3):239-44.

49. Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res. 1999 Sep;40(3):211-25.

50. Kidd PM. Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Altern Med Rev. 2005 Dec;10(4):268-93.

51. Kidd P. Phosphatidylserine: Nature’s Brain Booster for Memory, Mood, and Stress. St. George: Total Health Communications, Inc.; 2005.

52. Unpublished data, Enzymotec Ltd, Israel.

53. Nicholson CD. Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia. Psychopharmacology (Berl). 1990;101(2):147-59.

54. Gaal L, Molnar P. Effect of vinpocetine on noradrenergic neurons in rat locus coeruleus. Eur J Pharmacol. 1990 Oct 23;187(3):537-9.

55. Polich J, Gloria R. Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory. Hum Psychopharmacol. 2001 Jul;16(5):409-16.

56. Hindmarch I, Fuchs HH, Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol. 1991;6(1):31-43.

57. Horvath S. The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion. Orv Hetil. 2001 Feb 25;142(8):383-9.

58. Lendvai B, Zelles T, Rozsa B, Vizi ES. A vinca alkaloid enhances morphological dynamics of dendritic spines of neocortical layer 2/3 pyramidal cells. Brain Res Bull. 2003 Jan 15;59(4):257-60.

59. Hadjiev D. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine. Ideggyogy Sz. 2003 May 20;56(5-6):166-72.

60. Govindarajan R, Vijayakumar M, Pushpangadan P. Antioxidant approach to disease management and the role of ‘Rasayana’ herbs of Ayurveda. J Ethnopharmacol. 2005 Jun 3;99(2):165-78. Epub 2005 Apr 26.

61. [No authors listed] Monograph. Withania somnifera. Altern Med Rev. 2004 Jun;9(2):211-4.

62. Jain S, Shukla SD, Sharma K, Bhatnagar M. Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother Res. 2001 Sep;15(6):544-8.

63. Ahmad M, Saleem S, Ahmad AS. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol. 2005 Mar;24(3):137-47.

64. Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int. 1997 Feb;30(2):181-90.

65. Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal network. Neurosignals. 2005;14(1-2):34-45.

66. Ehlenfeldt MK, Prior RL. Oxygen radical absorbance capacity (ORAC) and phenolic and anthocyanin concentrations in fruit and leaf tissues of highbush blueberry. J Agric Food Chem. 2001 May;49(5):2222-7.

67. Bagchi D, Garg A, Krohn RL, et al. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol. 1998 May;30(5):771-6.

68. Bagchi D, Ray SD, Patel D, Bagchi M. Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract. Drugs Exp Clin Res. 2001;27(1):3-15.

69. Devi A, Jolitha AB, Ishii N. Grape seed proanthocyanidin extract (GSPE) and antioxidant defense in the brain of adult rats. Med Sci Monit. 2006 Apr;12(4):BR124-9.

70. Joseph JA, Shukitt-Hale B, Casadesus G. Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr. 2005 Jan;81(1 Suppl):313S-6S.

71. Andres-Lacueva C, Shukitt-Hale B, Galli RL, Jauregui O, Lamuela-Raventos RM, Joseph JA. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci. 2005 Apr;8(2):111-20.

72. Meydani M. Nutrition interventions in aging and age-associated disease. Ann N Y Acad Sci. 2001 Apr;928:226-35.

73. Bickford PC, Gould T, Briederick L, et al. Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res. 2000 Jun 2b;866(1-2):211-7.

74. Galli RL, Shukitt-Hale B, Youdim KA, Joseph JA.. Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann N Y Acad Sci. 2002 Apr;959:128-32.

75. Goyarzu P, Malin DH, Lau FC, et al. Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci. 2004 Apr;7(2):75-83.

76. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci. 1999 Sep 15;19(18):8114-21.

77. Casadesus G, Shukitt-Hale B, Stellwagen HM, et al. Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci. 2004 Oct;7(5-6):309-16.

78. Joseph JA, Denisova NA, Arendash G, et al. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci. 2003 Jun;6(3):153-62.

79. Galli RL, Bielinski DF, Szprengiel A, Shukitt-Hale B, Joseph JA. Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection. Neurobiol Aging. 2006 Feb;27(2):344-50.

80. Shi J, Yu J, Pohorly JE, Kakuda Y. Polyphenolics in grape seeds-biochemistry and functionality. J Med Food. 2003;6(4):291-9.

81. Li MH, Jang JH, Sun B, Surh YJ. Protective effects of oligomers of grape seed polyphenols against beta-amyloid-induced oxidative cell death. Ann NY Acad Sci. 2004 Dec;1030:317-29.

82. Balu M, Sangeetha P, Murali G, Panneerselvam C. Modulatory role of grape seed extract on age-related oxidative DNA damage in central nervous system of rats. Brain Res Bull. 2006 Feb 15;68(6):469-73.

83. Meieran SE, Reus VI, Webster R, Shafton R, Wolkowitz OM. Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation. Psychoneuroendocrinology. 2004 May;29(4):486-500.

84. Karishma KK, Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci. 2002 Aug;16(3):445-53.

85. Goncharova ND, Lapin BA. Effects of aging on hypothalamic-pituitary-adrenal system function in non-human primates. Mech Ageing Dev. 2002 Apr 30;123(8):1191-201.

86. Zietz B, Hrach S, Scholmerich J, Straub RH. Differential age-related changes of hypothalamus - pituitary - adrenal axis hormones in healthy women and men - role of interleukin 6. Exp Clin Endocrinol Diabetes. 2001;109(2):93-101.

87. Mayo W, Lemaire V, Malaterre J, et al. Pregnenolone sulfate enhances neurogenesis and PSA-NCAM in young and aged hippocampus. Neurobiol Aging. 2005 Jan;26(1):103-14.

88. Mayo W, George O, Darbra S, et al. Individual differences in cognitive aging: implication of pregnenolone sulfate. Prog Neurobiol. 2003 Sep;71(1):43-8.